News for NSPX Stock

Inspyr Therapeutics Reports Financial Results and Business Update For Full Year 2020 Inspyr Therapeutics Further Strengthens Global Intellectual Property Inspyr Therapeutics Strengthens Global Intellectual Property Inspyr Therapeutics Reports 2020 Third Quarter Results and Business Update Inspyr Therapeutics Acquires a Novel Immuno-Onoclogy Precision Targeting Platform for the Treatment of Cancer